Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys

Drug Metabolism and Disposition

Volumn 39, Issue 12, 2011, Pages 2233-2241

  Ferguson, C S ^a   Miksys, S ^a   Palmour, R ^b   Tyndale, Rachel F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORZOXAZONE; CYTOCHROME P450 2E1; LIVER ENZYME; NICOTINE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHLOROCEBUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SELF ADMINISTRATION; ENZYME ACTIVITY; ENZYME INDUCTION; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME METABOLISM; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CYTOCHROME P-450 CYP2E1; DNA PRIMERS; ETHANOL; MALE; MICROSOMES, LIVER; NICOTINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELF ADMINISTRATION;

ANIMALIA; CERCOPITHECUS AETHIOPS; PRIMATES;

EID: 81855228704     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.040378     Document Type: Article

References (41)

1. Amato G, Longo V, Mazzaccaro A, and Gervasi PG (1998) Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver. Drug Metab Dispos 26:483-489. (Pubitemid 28223889)
2. Barrett SP, Tichauer M, Leyton M, and Pihl RO (2006) Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend 81:197-204. (Pubitemid 41821803)
3. Benowitz NL and Jacob P 3rd (1984) Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 35:499-504. (Pubitemid 14133490)
4. Benowitz NL, Peng M, and Jacob P 3rd (2003) Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther 74:468-474. (Pubitemid 37357725)
5. Benowitz NL, Porchet H, and Jacob P 3rd (1990) Pharmacokinetics, metabolism, and pharmacodynamics of nicotine, in Nicotine Psychopharmacology: Molecular, Cellular and Behavioral Aspects (Wonnacott S, Russell MAH, and Stolerman IP eds) Oxford University Press, Oxford, UK.
6. Blomqvist O, Ericson M, Johnson DH, Engel JA, and Söderpalm B (1996) Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol 314:257-267. (Pubitemid 26382426)
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Caro AA and Cederbaum AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27-42. (Pubitemid 38263832)
9. Cooney JL, Cooney NL, Pilkey DT, Kranzler HR, and Oncken CA (2003) Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction 98:913-921. (Pubitemid 36808258)
10. Eckardt MJ, File SE, Gessa GL, Grant KA, Guerri C, Hoffman PL, Kalant H, Koob GF, Li TK, and Tabakoff B (1998) Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 22:998-1040. (Pubitemid 28408991)
11. Ernstgård L, Warholm M, and Johanson G (2004) Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol 58:190-200. (Pubitemid 39044000)
12. Ervin FR, Palmour RM, Young SN, Guzman-Flores C, and Juarez J (1990) Voluntary consumption of beverage alcohol by vervet monkeys: population screening, descriptive behavior and biochemical measures. Pharmacol Biochem Behav 36:367-373. (Pubitemid 20189797)
13. Hashimoto T, Yoneda M, Shimada T, Kurosawa M, and Terano A (2004) Intraportal nicotine infusion in rats decreases hepatic blood flow through endothelin-1 and both endothelin A and endothelin B receptors. Toxicol Appl Pharmacol 196:1-10. (Pubitemid 38393688)
14. Hayashi S, Watanabe J, and Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565.
15. Hukkanen J, Jacob Iii P, Peng M, Dempsey D, and Benowitz NL (2010) Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. Br J Clin Pharmacol 69:152-159.
16. Ivester P, Roberts LJ 2nd, Young T, Stafforini D, Vivian J, Lees C, Young J, Daunais J, Friedman D, Rippe RA, et al. (2007) Ethanol self-administration and alterations in the livers of the cynomolgus monkey, Macaca fascicularis. Alcohol Clin Exp Res 31:144-155. (Pubitemid 46025377)
17. Joshi M and Tyndale RF (2006) Induction and recovery time course of rat brain CYP2E1 after nicotine treatment. Drug Metab Dispos 34:647-652.
18. Lands WE (1998) A review of alcohol clearance in humans. Alcohol 15:147-160.
19. Lê AD, Corrigall WA, Harding JW, Juzytsch W, and Li TK (2000) Involvement of nicotinic receptors in alcohol self-administration. Alcohol Clin Exp Res 24:155-163. (Pubitemid 30117416)
20. Leclercq I, Horsmans Y, and Desager JP (1998) Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method. J Chromatogr A 828:291-296. (Pubitemid 29046428)
21. Lee AM, Miksys S, Palmour R, and Tyndale RF (2006a) CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment. Neuropharmacology 50:441-450. (Pubitemid 43209040)
22. Lee AM, Yue J, and Tyndale RF (2006b) In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment. Drug Metab Dispos 34:1508-1515. (Pubitemid 44285392)
23. Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517-544.
24. Liu R, Yin LH, and Pu YP (2007) Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Chin Med J (Engl) 120:1797-1802. (Pubitemid 350111086)
25. Matsumoto H, Matsubayashi K, and Fukui Y (1996) Evidence that cytochrome P-4502E1 contributes to ethanol elimination at low doses: effects of diallyl sulfide and 4-methyl pyrazole on ethanol elimination in the perfused rat liver. Alcohol Clin Exp Res 20:12A-16A.
26. Micu AL, Miksys S, Sellers EM, Koop DR, and Tyndale RF (2003) Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism. J Pharmacol Exp Ther 306:941-947. (Pubitemid 37025299)
27. Millonig G, Wang Y, Homann N, Bernhardt F, Qin H, Mueller S, Bartsch H, and Seitz HK (2011) Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 128:533-540.
28. Morita M, Le Marchand L, Kono S, Yin G, Toyomura K, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, et al. (2009) Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev 18:235-241.
29. Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, Oda S, and Katoh T (2003) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 129:355-360. (Pubitemid 36963198)
30. Olausson P, Ericson M, Löf E, Engel JA, and Söderpalm B (2001) Nicotine-induced behavioral disinhibition and ethanol preference correlate after repeated nicotine treatment. Eur J Pharmacol 417:117-123. (Pubitemid 32299874)
31. Oneta CM, Lieber CS, Li J, Rüttimann S, Schmid B, Lattmann J, Rosman AS, and Seitz HK (2002) Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47-52. (Pubitemid 34234015)
32. Palmour RM, Mulligan J, Howbert JJ, and Ervin F (1997) Of monkeys and men: vervets and the genetics of human-like behaviors. Am J Hum Genet 61:481-488. (Pubitemid 27418387)
33. Roberts BJ, Song BJ, Soh Y, Park SS, and Shoaf SE (1995) Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270:29632-29635.
34. Ronis MJ, Huang J, Crouch J, Mercado C, Irby D, Valentine CR, Lumpkin CK, Ingelman-Sundberg M, and Badger TM (1993) Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats. J Pharmacol Exp Ther 264:944-950. (Pubitemid 24283562)
35. Sharpe AL and Samson HH (2002) Repeated nicotine injections decrease operant ethanol self-administration. Alcohol 28:1-7.
36. Shiffman S and BalbanisM(1995) Associations between Alcohol and Tobacco. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
37. Vidal F, Perez J, Morancho J, Pinto B, and Richart C (1990) Hepatic alcohol dehydrogenase activity in alcoholic subjects with and without liver disease. Gut 31:707-711. (Pubitemid 20209046)
38. Wang W, Qiu YL, Ji F, Liu J, Wu F, Miao WB, Li Y, Brandt-Rauf PW, and Xia ZL (2010) Genetic polymorphisms in metabolizing enzymes and susceptibility of chromosomal damage induced by vinyl chloride monomer in a Chinese worker population. J Occup Environ Med 52:163-168.
39. Wu D, Ramin SA, and Cederbaum AI (1997) Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture. Mol Cell Biochem 173:103-111. (Pubitemid 27389084)
40. Yue J, Khokhar J, Miksys S, and Tyndale RF (2009) Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake. Eur J Pharmacol 609:88-95.
41. Zhang Y, Liu Q, Liu Q, Duan H, Cheng J, Jiang S, Huang X, Leng S, He F, and Zheng Y (2006) Association between metabolic gene polymorphisms and susceptibility to peripheral nerve damage in workers exposed to n-hexane: a preliminary study. Biomarkers 11:61-69. (Pubitemid 43250552)